Skip to main content
Safe S.A. logo

Safe S.A. — Investor Relations & Filings

Ticker · ALSAF ISIN · FR001400F1V2 LEI · 969500DG8YK9AV60FN03 Euronext Growth Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2025-03-12 Regulatory Filings
Country FR France
Listing Euronext Growth ALSAF

About Safe S.A.

https://www.safeorthopaedics.com/

Safe S.A., operating through its Safe Metal division, is a company specializing in the co-design and production of cast steel components. Utilizing green sand casting processes, the company manufactures essential parts for various industrial applications. Safe Metal positions itself as a world leader in its field, collaborating with clients to develop and supply critical components.

Recent filings

Filing Released Lang Actions
SAFE GROUP - Signature d’un important contrat avec un hôpital texan
Regulatory Filings Classification · 1% confidence The document announces the signing of a significant contract with a Texas hospital for spinal solutions. It details the nature of the agreement, includes quotes from management (CEO), and provides background information about the company (Safe Group, Safe Orthopaedics, Safe Medical). This type of announcement, focusing on a major business development or contract win, does not fit neatly into standard periodic financial reports (10-K, IR, ER) or specific corporate actions (DIV, SHA, POS). It is a material business update. Given the options, it is best classified as a general Regulatory Filing (RNS) as it is a press release announcing a significant business event, or potentially a general announcement that doesn't fit the specific categories like M&A (TAR) or Financing (CAP). Since it is a press release announcing a business development, RNS is the most appropriate fallback category for non-standard, material announcements.
2025-03-12 French
SAFE GROUP - ACCELERATION DU DEPLOIEMENT EN COLOMBIE
Regulatory Filings Classification · 1% confidence The document is a press release from Safe Group announcing the expansion of their medical device deployment in Colombia and their participation in a medical conference. It does not report financial results, governance changes, or regulatory filings, but rather serves as a general corporate update regarding business operations and market expansion. As it does not fit into specific categories like earnings, dividends, or legal proceedings, it falls under the general regulatory/corporate announcement category.
2025-02-19 French
SAFE GROUP - CHIFFRE D’AFFAIRES 2024
Earnings Release Classification · 1% confidence The document is titled 'CHIFFRE D'AFFAIRES 2024' (2024 Revenue) and explicitly states that Safe Group is publishing its 'chiffre d'affaires annuel consolidé réalisé sur l'exercice 2024' (consolidated annual revenue for the 2024 fiscal year). It provides key financial figures (revenue in K€ for 2024 vs 2023) and discusses business restructuring and future outlook. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, typically focusing on key highlights like revenue before the full Annual Report (10-K) or detailed Management Discussion and Analysis (MDA) is filed. Since it is a summary announcement of annual results, ER is the most appropriate classification over IR (Interim Report) or 10-K (Full Annual Report). The document length (4028 chars) is consistent with a brief release. FY 2024
2025-02-12 French
SAFE GROUP - 16èmes Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires : présentation des résultats cliniques du Professeur Maestretti sur le dispositif Sycamore
Regulatory Filings Classification · 1% confidence The document is a press release dated January 7, 2025, announcing that Professor Maestretti will present clinical results on the Sycamore device at the '16èmes Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires' on January 24, 2025. It details a medical technology advancement and its presentation at a conference. This type of announcement, focusing on clinical data presentation at an industry event, is best classified as a general regulatory announcement or news release that doesn't fit the specific financial filing codes (like 10-K, ER, or IR). Given the options, 'Regulatory Filings' (RNS) serves as the most appropriate general category for corporate news releases that are not standard financial reports or specific corporate actions like dividends or management changes. It is not an Earnings Release (ER), Interim Report (IR), or Investor Presentation (IP) in the formal sense, but rather a news item about an upcoming presentation.
2025-01-07 French
SAFE GROUP - 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires: presentation of Professor Maestretti's clinical results on the Sycamore device
Environmental & Social Information Classification · 1% confidence The document is a press release announcing that Professor Maestretti will present clinical results on the 'Sycamore device' at an upcoming medical conference ('16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires'). It details the significance of the device and the company (Safe Orthopaedics) but does not contain comprehensive financial statements (like 10-K or IR), management changes (MANG), or voting results (DVA). It is an announcement about company activity and product development, which is often categorized under general regulatory/investor communications. Since there is no specific category for 'Product/Clinical Update Announcement,' and it is not a formal financial report, it fits best as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were the presentation itself, but as a press release *about* a presentation, RNS is the most appropriate fallback for non-standard corporate news.
2025-01-07 English
SAFE - Assemblée générale mixte du 30 décembre 2024
AGM Information Classification · 1% confidence The document explicitly mentions 'Assemblée générale mixte du 30 décembre 2024' (Mixed General Meeting of December 30, 2024) and details the resolutions approved by the shareholders, including financial approvals and capital reduction measures. The presence of detailed voting results in the annex confirms this is documentation related to a shareholder meeting. This aligns perfectly with the definition of AGM Information (AGM-R). Although capital structure changes (Resolution 8, 9, 10) are discussed, the primary context and structure are that of the meeting's outcome report.
2025-01-06 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.